Cancer is
still a major health concern worldwide, and its complexity necessitates the use
of a variety of therapeutic strategies. This abstract explores the complexities
of cancer, explaining the many forms and underlying causes of interdisciplinary
synergy between oncology and nanotechnology. It navigates through the molecular
pathways and genetic abnormalities linked to the onset and development of
cancer through thorough examination. It also illuminates the rapidly developing
science of nanotechnology and its potential to transform cancer detection and
therapy. Knowledge of cancer’s various forms, from carcinoma to sarcoma, each
with its own biological origins and clinical characteristics is essential to
understanding the disease. Examining the genesis of cancer reveals a complex
picture that includes lifestyle variables, environmental exposures, and genetic
predispositions. Deciphering these complexities offers vital information for
focused treatment approaches. Nanotechnology is emerging as a paradigm-shifting
force in cancer therapies, providing novel approaches to early diagnosis,
imaging, and precise medication administration. Because of their specific
characteristics and surface changes, nanoparticles have the most promise for getting
past biological barriers, increasing the effectiveness of treatments, and
reducing side effects. Furthermore, this abstract provides light on a way
forward for better cancer management techniques. Integrating insights is to
battle this unstoppable illness with tailored and targeted methods by fusing
advances in nanotechnology with insights into cancer biology.
Atıf Sayısı :